Novo Nordisk is expanding access to its drug Wegovy through a new partnership with WeightWatchers, days after cutting ties with telehealth firm Hims & Hers.
Starting July 1, WeightWatchers will collaborate with Humana’s CenterWell Pharmacy to fulfill and deliver prescriptions for Wegovy, with an aim to simplify access to the medication, according to a June 26 news release from the drugmaker.
As part of the new partnership, Novo Nordisk will launch a temporary $299 cash offer price for Wegovy from July 1-31. The offer applies to self-pay patients who are new to the company’s savings program or have not yet filled a prescription through NovoCare Pharmacy.
The move follows Novo Nordisk’s abrupt termination of its partnership with Hims & Hers, alleging the telehealth firm sold knockoff versions of Wegovy and for using deceptive marketing practices.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
